Gene variant linked to higher risk of chronic rejection after lung transplant
About one third of lung transplant recipients have a genetic variant that makes them more likely to develop…
New fluorescent sensor allows scientists to watch DNA damage and repair in real time
Cancer research, drug safety testing and ageing biology may all gain a major boost from a new fluorescent…
T cells drive vaccine effectiveness against porcine reproductive and respiratory syndrome virus
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV)…
Northwestern team develops antibody to expose hidden pancreatic cancer cells
Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have…
Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and…
Integrating physicochemical laws into future AI models for better drug design
Proteins play a key role not only in the body, but also in medicine: they either serve as…
Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments | Military Medical Research
Ulaeto D, Agafonov A, Burchfield J, Carter L, Happi C, Jakob R, et al. New nomenclature for mpox…
New insights into malaria proteins offer pathway to blocking parasite transmission
Using millions of microscope images magnified up to 130,000 times, researchers from Radboud university medical center and Toronto…
Bispecific Antibodies Market – Global Forecast 2025-2032,
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) — The “Bispecific Antibodies Market – Global Forecast 2025-2032” report has been…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus
Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent,…
New microfluidic-based biosensing platform helps track live antibody secretion dynamics
A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong…